Extended Data Fig. 1: Concordance between SP263 assay with TAP score and 28-8 assay with CPS.

PD-L1 expression levels observed using the VENTANA SP263 assay with TAP scoring at ≥1% and ≥5% cutoffs and the Dako PharmDx 28-8 PD-L1 assay with CPS scoring. CPS, combined positivity score; TAP, tumor area positivity.